Robert E. Waltermire - 16 Jan 2024 Form 4 Insider Report for MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Role
Senior VP, Chief Pharma Dev.
Signature
/s/ Brian J. Lynch*
Issuer symbol
MDGL
Transactions as of
16 Jan 2024
Net transactions value
-$134,156
Form type
4
Filing time
18 Jan 2024, 13:45:26 UTC
Previous filing
18 Dec 2023
Next filing
25 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDGL Common Stock Tax liability $134,156 -550 -9.7% $243.92 5,117 16 Jan 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents withholding of shares as payment of the Reporting Person's tax liabilities incident to the vesting of restricted stock units granted to the Reporting Person on January 16, 2023.

Remarks:

*As attorney-in-fact for Reporting Person